NICE Ltd., headquartered in Ra'anana, Israel, sells AI-powered cloud platforms for customer engagement (CXone) and financial crime and compliance (Actimize). The stock trades as an American Depositary Receipt on Nasdaq under the ticker NICE.
The $135 figure is not a published "official consensus" but an average I calculated from individual, attributed targets. Recent examples include Oppenheimer (upgrade, $150, late September 2026), RBC Capital (raised to $145 from $130), D.A. Davidson ($140), Yorkville Ives (initiated at $125), and Citizens JMP (Market Outperform, $170). On the cautious side, Morgan Stanley moved to Equal-Weight with a $111 target, while Wedbush ($100), Cantor Fitzgerald ($104), and Citigroup ($100) sit at the lower end. The full range runs from $100 to $170.
The dispersion is meaningful: bulls argue the shift to AI-first software can re-rate the stock, while cautious analysts worry about slower near-term profit growth. No single target is more likely than another; the average simply summarizes the range.
NICE shares closed most recently near $106.27, down roughly 5% in a single session and about 21% year to date against a rising broader market. Reaching $135 would require a move of approximately 27%, which qualifies as a substantial advance rather than a modest drift.
The path would likely depend on re-accelerating growth in the core CXone cloud platform, clearer monetization of generative-AI capabilities, and a return to earnings expansion. Consensus estimates see revenue of about $3.2 billion this year (up roughly 8%) and $3.5 billion next year, but EPS is projected to dip to around $11 in 2026 from $12.30 in 2025 before recovering in 2027. At roughly $106, the stock trades near 15 times trailing earnings and under 9 times forward estimates, a discounted multiple that leaves room for re-rating if execution improves.
NICE has traded in a 52-week range of roughly $83.10 to about $138. The $100 level is a psychologically important zone and coincides with several cautious analyst targets, acting as a support area, with the $83 low beneath it. On the upside, the stock must first reclaim its recent breakdown area near $112–$115, then the $130s, where the prior highs and several targets cluster. The $135 target sits just under that resistance band, meaning a durable move above it would likely require a genuine re-rating, not just a technical bounce.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms differ and none should be read as a timing guarantee. The most important near-term event is the company's quarterly earnings report, due in early November 2026, which will test revenue-growth and EPS expectations. Investors should watch guidance, cloud bookings and retention metrics, commentary on AI monetization and agent-seat trends, and any subsequent analyst target revisions. Broader software-sector valuation and interest-rate conditions also matter.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders spot changing trends, monitor existing positions, and surface new opportunities more efficiently than manual screening. For investors tracking a volatile name like NICE, automated signal monitoring can add a layer of discipline to the research process.
Can NICE reach $135? The question is answerable only in probabilities, not certainties. The target is the average of roughly 14 analyst price targets ranging from $100 to $170, implying a substantial 27% advance from the current level near $106. Support rests on cloud and AI momentum and a discounted valuation, while the principal obstacles are generative AI's threat to traditional agent-based economics and near-term earnings pressure. With analysts split between bullish and cautious views and a key earnings report approaching, the answer will likely hinge on whether the company can show that AI expands its opportunity rather than eroding it. Investors should weigh the wide target range and monitor execution rather than treat the average as a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, NICE has been loosely correlated with CLSK. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if NICE jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To NICE | 1D Price Change % | ||
|---|---|---|---|---|
| NICE | 100% | +2.04% | ||
| CLSK - NICE | 60% Loosely correlated | -2.78% | ||
| COIN - NICE | 59% Loosely correlated | -2.31% | ||
| FIVN - NICE | 57% Loosely correlated | -3.09% | ||
| RIOT - NICE | 55% Loosely correlated | -1.74% | ||
| BL - NICE | 54% Loosely correlated | +3.69% | ||
More | ||||
| Ticker / NAME | Correlation To NICE | 1D Price Change % |
|---|---|---|
| NICE | 100% | +2.04% |
| Technology Services category (396 stocks) | 16% Poorly correlated | -0.36% |
| Packaged Software category (222 stocks) | 16% Poorly correlated | -1.06% |